The digestive system is a complex, interconnected network, so when one part shifts its behaviour, the others often respond as well
It enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
FDA Designations for ARD-101 The FDA approves ARD-101 Orphan Drug designation and Rare Pediatric Disease designation for its potential to treat Prader-Willi Syndrome
Ozempic is semaglutide, a single GLP-1 receptor agonist, while retatrutide is a triple-agonist that targets GLP-1, GIP, and glucagon receptors
The gradual, sustained weight loss pattern is healthier than rapid weight loss and more likely to be kept long-term
The barriers are lower than most people expect, and getting started takes considerably less time than navigating a traditional specialist referral